Geoffrey Trenkle, DO
Facial Plastic Surgery · Los Angeles, CANPI 1003044876
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (55.8%), food and beverage and gifts — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Medical Device Business Services, Inc. at 54.0% of the total. Reporting peaked in 2019 at $24,706 and has fallen 94.2% since, to $1,431 in 2025. Among facial plastic surgery clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 201 payments — averaging $216.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$24K
- Stryker$6K
- Olympus America Inc.$5K
- Aerin Medical Inc.$4K
- Acclarent, Inc$1K
- Medtronic$984
- plus $3K from 14 others
What the payments were for
- Consulting fees$24,27556%
- Speaking & faculty fees$2000%
- Travel & lodging$2,1685%
- Food & beverage$12,23628%
- Gifts$4,64511%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 12 | $23,514 |
| Stryker | 74 | $6,308 |
| Olympus America Inc. | 3 | $4,745 |
| Aerin Medical Inc. | 17 | $4,157 |
| Acclarent, Inc | 27 | $1,134 |
| Medtronic | 11 | $984 |
| Optinose US, Inc. | 24 | $660 |
| Neurent Medical Limited | 9 | $456 |
| Inspire Medical Systems, Inc. | 2 | $318 |
| Smith+Nephew | 4 | $268 |
| Hologic Sales And Service, LLC | 3 | $172 |
| Integra Lifesciences Corporation | 4 | $160 |
| Covidien LP | 3 | $150 |
| Sanofi | 1 | $125 |
| Regeneron Healthcare Solutions, Inc. | 1 | $115 |
| Haag-streit USA, Inc. | 1 | $100 |
| Intersect ENT, Inc. | 2 | $92 |
| Cochlear Americas | 1 | $27 |
| AbbVie | 1 | $23 |
| Galderma Laboratories, L.p. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACCLARENT NAVWIRE Sinus Navigation Guidewire$12,548
- TruDi Nav Cable$12,329
- TruDi Navigation System$12,213
- TruDi Nav Suction$12,213
- ENT Videoscopes$4,645
- Surgical Light Sources$4,645
- Surgical Processors$4,645
- ENT Rigid Sinuscopes$4,645
- Carts Rollstands & Mounting Solu$4,645
- VivAer$2,968
- RhinAer$2,968
- XPRESS ENT DILATION SYSTEM$1,940
- ENTELLUS - XPRESS ENT DILATION SYSTEM$1,122
- Xhance$360
- VIVAER STYLUS$345
- RHINAER STYLUS$345
- LigaSure$318
- Inspire$318
- SCOPIS ENT$256
- FIAGON NAVIGATION UNIT$253
How this compares
$43,524 in reported general payments places this provider in the 90th percentile of 120 facial plastic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 11 | $40,640 |
| XhanceFluticasone Propionate | 34 | $21,942 |
| Azelastine Hcl | 950 | $18,597 |
| Epinephrine | 54 | $10,958 |
| Fluticasone Propionate | 870 | $7,880 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 70 | $7,639 |
| Ipratropium Bromide | 277 | $7,330 |
| Dexlansoprazole DrDexlansoprazole | 12 | $3,767 |
| Ofloxacin | 72 | $2,538 |
| Diclofenac Sodium | 131 | $1,856 |
| Fluocinolone Acetonide Oil | 53 | $1,613 |
| Famotidine | 228 | $1,549 |
| Omeprazole | 99 | $1,165 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 98 | $852 |
| Clotrimazole | 23 | $686 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Optinose US, Inc.Xhance | $660 | $21,94234 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 120 facial plastic surgery providers in California.
Other facial plastic surgery in Los Angeles
- Kian KarimiLos Angeles$1.2M
- Behrooz TorkianLos Angeles$15K
- Amit KochharLos Angeles$4K
- Daniel SukatoLos Angeles$2K
- Carlo HonradoLos Angeles$2K
- Anna HsuLos Angeles$2K
- Henry ChenLos Angeles$1K
- Steven LeeLos Angeles$1K
- Nicholas SchenckLos Angeles$1K
- Andrew ChoiLos Angeles$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.